Monday, August 4, 2025 Markets reversed Friday’s selloff with relative ease today, hitting the tape in the green this morning and staying higher throughout the session. It’s a clear bounce-back to ...

Monday closed up +1.47%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.34%, and the Nasdaq 100 Index ($IUXX) ...

Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their ...

The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national ...

Estimate trends have been broadly positive heading into the print: EPS estimates have seen 7 upward revisions and 3 downward over the past 90 days. Revenue estimates have been revised upward 8 times, ...

BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...

Analysts estimate that Pfizer will report an earnings per share (EPS) of $0.58. The market awaits Pfizer's announcement, with ...

Pfizer Inc. (NYSE:PFE) reported in its fiscal Q1 2025 results that the first phase of its manufacturing optimization program ...

Pfizer's strong EPS surprise streak and positive earnings revisions are encouraging, but patent cliff risks remain a major ...

As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that ...

Pfizer Inc. (NYSE:PFE) will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5.

German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 million euros ($302 million ...